natgillin/translations-raw huggingface dataset:
AstraZeneca UK Limited Silk Road Business Park, Macclesfield, Cheshire, SK10 2NA United Kingdom 
AstraZeneca UK Limited Silk Road Business Park, Macclesfield, Cheshire, SK10 2NA Velika Britanija
Note: This needs to be done after each injection 
Opomba: To je treba narediti po vsakem injiciranju.
In the event of overdose, appropriate supportive treatment (possibly given parenterally) should be initiated according to the patient's clinical signs and symptoms. 
V primeru prevelikega odmerjanja je potrebno začeti z ustreznim podpornim zdravljenjem (če je mogoče, danim parenteralno) glede na bolnikove klinične znake in simptome.
• A small air bubble is normal. 
• Majhen zračni mehurček je običajen.
No clinically relevant effects on Cmax or AUC were observed. 
Klinično pomembnih učinkov na Cmax ali AUC niso opazili.
In most patients who develop antibodies, antibody titres diminish over time and remain low through 82 weeks. 
Pri večini bolnikov, ki razvijejo protitelesa, se titri protiteles s časom zmanjšajo in ostanejo nizki v obdobju 82 tednov.
The clinical experience in patients > 75 years is very limited. 
Klinične izkušnje pri bolnikih > 75 let so zelo omejene.
It should be injected under the skin and not into a vein or into the muscle. 
Injicirajte si ga pod kožo in ne v veno ali v mišico.
When the pen is empty, you cannot use it again. 
Ko je injekcijski peresnik prazen, ga ne morete ponovno uporabiti.
Studies in animals have shown reproductive toxicity (see section 5.3). 
Študije pri živalih so pokazale reproduktivno toksičnost (glejte poglavje 5.3).
Do not use an extra dose or increase the amount of your next dose to make up for the one you missed. 
Ne uporabite dodatnega odmerka in ne povečajte količine vašega naslednjega odmerka, da bi nadomestili odmerek, ki ste ga izpustili.
In addition some other side effects have been reported (frequency not known, cannot be estimated from the available data). 
Dodatno so poročali tudi o nekaterih drugih neželenih učinkih (pogostnost ni znana in je ni mogoče oceniti na podlagi razpoložljivih podatkov):
Why are there air bubbles in the cartridge? 
Zakaj so v vložku zračni mehurčki?
− Some antibiotics may need to be taken an hour before your Byetta injection. 
- nekatere antibiotike bo morda treba vzeti eno uro pred injiciranjem zdravila Byetta.
Your doctor should tell you how to treat low blood sugar. 
Vaš zdravnik naj vam pove, kako zdraviti nizek sladkor v krvi.
Now that you have done the New Pen Setup, follow Section 3 for all of your injections. 
Sedaj ko ste zaključili pripravo novega injekcijskega peresnika, sledite Poglavju 3 za vse vaše nadaljnje injekcije.
Changes in LDL-C or total cholesterol are possible, however, no predetermined dose adjustment is required. 
Spremembe v LDL-C ali skupnem holesterolu so možne, vendar vnaprejšnja prilagoditev odmerka ni potrebna.
Exenatide is not a substitute for insulin. 
Eksenatid ni nadomestilo za insulin.
Do not use this medicine after your meal. 
Ne uporabite tega zdravila po vašem obroku.
If you are using Byetta and an insulin you must make two separate injections. 
Če uporabljate zdravilo Byetta in insulin, morate pripraviti dve ločeni injekciji.
Patients should be informed of the characteristic symptom of acute pancreatitis: persistent, severe abdominal pain. 
Bolnike je potrebno obvestiti o značilnih simptomih akutnega pankreatitisa: vztrajni, hudi bolečini v trebuhu.
With continued therapy, the frequency and severity decreased in most patients who initially experienced nausea. 
Z nadaljevanjem zdravljenja sta se pogostnost in resnost zmanjšali pri večini bolnikov, ki so na začetku občutili navzeo.
• The needle may be clogged, bent, or incorrectly attached. 
• Igla je morda zamašena, zvita ali nepravilno pritrjena.
If you feel you should stop using this medicine, consult your doctor first. 
Če menite, da bi prenehali uporabljati to zdravilo, se o tem najprej posvetujte s svojim zdravnikom.
Beta-cell function 
Delovanje beta celic
- If you have type 1 diabetes or diabetic ketoacidosis (a dangerous condition that can occur in diabetes), as you should not use this medicine. 
- Če imate sladkorno bolezen tipa 1 ali diabetično ketoacidozo (nevarno bolezensko stanje, ki se lahko pojavi pri sladkorni bolezni), ker ne smete uporabiti tega zdravila.
Instructions for use Byetta is for use by one person only. 
Zdravilo Byetta je za uporabo le za eno osebo.
- If you are allergic to exenatide or any of the other ingredients of this medicine (listed in section 6). 
- Če ste alergični na eksenatid ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
• New Pen Setup is now done. 
• Priprava novega peresnika je sedaj zaključena.
This medicine may reduce your appetite, the amount of food you eat, and your weight. 
To zdravilo lahko zmanjša vaš apetit, količino zaužite hrane in vašo telesno maso.
Patients receiving medicinal products of either a narrow therapeutic ratio or medicinal products that require careful clinical monitoring should be followed closely. 
Bolnike, ki dobivajo zdravila z ozkim terapevtskim razmerjem ali zdravila, ki zahtevajo skrben klinični nadzor, moramo skrbno spremljati.
For this group, the level of glycaemic control (HbA1c) was generally comparable to that observed in those without antibody titres. 
Za to skupino je bila stopnja glikemičnega nadzora (HbA1c) na splošno primerljiva s stopnjo, opazovano pri tistih brez titrov protiteles.
If you use more of this medicine than you should, talk to a doctor or go to a hospital right away. 
Če ste uporabili večji odmerek tega zdravila, kot bi smeli, se takoj posvetujte z zdravnikom ali odidite v bolnišnico.
Table 2: Combined results of the 30-week placebo-controlled studies (intent to treat patients) 
Preglednica 2: Kombinirani rezultati 30 tedenskih, s placebom nadzorovanih študij (na zdravljenje pripravljeni bolniki)
If is in the dose window: 
Če je v okencu za odmerjanje :
Gender and race Gender and race have no clinically relevant influence on exenatide pharmacokinetics. 
Spol in rasa Spol in rasa nimata klinično značilnega vpliva na farmakokinetiko eksenatida.
These medical conditions can increase your chance of getting pancreatitis, or getting it again, whether or not you are taking this medicine. 
Te motnje namreč povečujejo možnost, da dobite (ali znova dobite) pankreatitis, ne glede na to, ali uporabljate to zdravilo ali ne.
The active substance in this medicine slows stomach emptying so food passes more slowly through your stomach. 
Zdravilna učinkovina v tem zdravilu upočasni praznjenje želodca, tako da hrana počasneje potuje skozi vaš želodec.
This medicine is for you; never share a Byetta pen with others. 
To zdravilo je namenjeno vam osebno; injekcijskega peresnika Byetta nikoli ne delite z drugimi.
Paracetamol was used as a model medicinal product to evaluate the effect of exenatide on gastric emptying. 
Paracetamol so uporabili kot model zdravila za vrednotenje učinkov eksenatida na praznjenje želodca.
• Tell your doctorif you have had pancreatitis, gallstones, alcoholism or very high triglycerides. 
• Zdravniku morate povedati, če ste kdaj imeli pankreatitis, žolčne kamne, alkoholizem ali zelo visoke trigliceride.
NEEDLE PARTS (Needles Not Included) 
SESTAVNI DELI IGLE (igle niso priložene)
If you miss a dose of this medicine, skip that dose and use your next dose at the next prescribed time. 
Če ste pozabili na odmerek tega zdravila, ta odmerek izpustite in uporabite vaš naslednji odmerek ob naslednjem predpisanem času.
Pancreatitis can be a serious, potentially life-threatening medical condition. 
Pankreatitis je lahko resna in celo smrtno nevarna bolezen.
Read this section completely before you begin. 
Preden začnete, natančno preberite to poglavje.
See Commonly Asked Question 4. 
Glejte Pogosta vprašanja, vprašanje št. 4.
Nonclinical studies have shown that exenatide is predominantly eliminated by glomerular filtration with subsequent proteolytic degradation. 
Neklinične študije so pokazale, da se eksenatid izloča pretežno z glomerulno filtracijo z nadaljnjo proteolitično razgradnjo.
Specific recommendations regarding intake of such medicinal products in relation to immediate-release exenatide is given in section 4.5. 
Posebna priporočila glede jemanja takih zdravil v zvezi z eksenatidom v obliki s takojšnjim sproščanjem so podana v poglavju 4.5.
However, exenatide does not impair the normal glucagon response and other hormone responses to hypoglycaemia. 
Vendar eksenatid ne poslabša običajnega odgovora glukagona in ostalih hormonov na hipoglikemijo.
Other medicines and Byetta 
Druga zdravila in zdravilo Byetta
If an injection is missed, the treatment should be continued with the next scheduled dose. 
Če injekcijo izpustimo, moramo zdravljenje nadaljevati z naslednjim načrtovanim odmerkom.
Byetta is not an insulin and should therefore not be used as a substitute for insulin. 
Zdravilo Byetta ni insulin in se zato ne sme uporabljati kot njegovo nadomestilo.
• If any part of your pen appears broken or damaged, do not use the pen. 
• Če je kateri koli del vašega injekcijskega peresnika videti zlomljen ali poškodovan, tega peresnika ne uporabite.
International normalised ratio increased with concomitant warfarin, some reports associated with bleeding 
Povišano mednarodno umerjeno razmerje s sočasno uporabo varfarina, nekaj poročil povezanih s krvavitvijo
• Swelling of theface, tongue or throat(angioedema) 
• oteklost obraza, jezika ali žrela (angiodem)
If you are over 70 years old or have problems with your kidneys it may take longer than 30 days to tolerate the Byetta 5 micrograms dose and so your doctor may not increase your dose. 
Če ste starejši od 70 let ali imate težave z ledvicami, bo morda potebno več kot 30 dni za doseg tolerance za odmerek 5 mikrogramov (µg) zdravila Byetta in vaš zdravnik odmerka morda ne bo zvišal.
Exenatide has minor influence on the ability to drive and use machines. 
Eksenatid ima majhen vpliv na sposobnost vožnje in upravljanja s stroji.
Some of these events occurred in patients experiencing events that may affect hydration, including nausea, vomiting, and/or diarrhoea and/or receiving medicinal products known to affect renal function/hydration status. 
Nekateri izmed teh dogodkov so se pojavili pri bolnikih, ki so izkusili stanja, ki lahko vplivajo na hidracijo, vključno z navzeo, bruhanjem in/ali diarejo in/ali so prejemali zdravila z učinkom na delovanje ledvic/stanje hidracije.
The European Medicines Agency has deferred the obligation to submit the results of studies with immediate-release exenatide in one or more subsets of the paediatric population in type 2 diabetes mellitus (see section 4.2 for information on paediatric use). 
Evropska agencija za zdravila je odložila obveznost za predložitev rezultatov študij z eksenatidom v obliki s takojšnjim sproščanjem na eni ali več podskupinah pediatrične populacije z diabetesom mellitusom tipa 2 (za informacije o pediatrični uporabi glejte poglavje 4.2).
Digoxin, lisinopril and warfarin 
Digoksin, lizinopril in varfarin
Resolution of pancreatitis has been observed with supportive treatment but very rare cases of necrotising or hemorrhagic pancreatitis and/or death have been reported. 
Ob podpornem zdravljenju so opažali izboljšanje pankreatitisa, vendar so opisani tudi zelo redki primeri nekrotizirajočega ali hemoragičnega pankreatitisa in/ali smrt.
Do not use Byetta if it has been frozen. 
Zdravila Byetta ne smete uporabiti, če je bilo zamrznjeno.
Examination of antibody-positive specimens from one long-term uncontrolled study revealed no significant cross-reactivity with similar endogenous peptides (glucagon or GLP-1). 
Preiskava vzorcev s pozitivnimi protitelesi iz dolgoročne nenadzorovane študije ni pokazala značilne navzkrižne reaktivnosti s podobnimi endogenimi peptidi (glukagon ali GLP-1).
The reactions are listed below as MedDRA preferred term by system organ class and absolute frequency. 
Neželeni učinki so navedeni kot MedDRA preferenčni izrazi glede na razred organskega sistema in absolutno pogostnost.
Pharmacotherapeutic group: Glucagon-like peptide-1 (GLP-1) analogues, ATC code: A10BJ01. 
Farmakoterapevtska skupina: Analogi glukagonu podobnega peptida-1 (GLP-1), oznaka ATC: A10BJ01.
The experience in patients > 65 years and in patients with impaired renal function is limited. 
Izkušnje pri bolnikih > 65 let in pri bolnikih z okvaro ledvic so omejene.
• Do not share your pen or needles as this may risk transmission of infectious agents. 
• Svojega injekcijskega peresnika ali igel ne delite z drugimi, saj lahko tvegate prenos okuženih delcev.
The clinical studies comprised 3945 subjects (2997 treated with exenatide), 56% men and 44% women, 319 subjects (230 treated with exenatide) were ≥ 70 years of age and 34 subjects (27 treated with exenatide) were ≥ 75 years of age. 
Klinične študije so vključevale 3945 oseb (2997 zdravljenih z eksenatidom), 56 % moških in 44 % žensk, 319 oseb (230 zdravljenih z eksenatidom) je bilo ≥ 70 let in 34 oseb (27 zdravljenih z eksenatidom) je bilo ≥ 75 let.
You should inject this medicine under the skin (subcutaneous injection) of your upper leg (thigh), stomach area (abdomen), or upper arm. 
To zdravilo si morate injicirati pod kožo (subkutana injekcija) zgornjega dela vaše noge (stegno), področja trebuha (abdomna) ali nadlakti.
About half of this 6% (3% of the total patients given immediate-release exenatide in the controlled studies), had no apparent glycaemic response to immediate-release exenatide. 
Približno polovica teh 6 % (3 % vseh bolnikov, ki so v nadzorovanih študijah dobivali eksenatid v obliki s takojšnjim sproščanjem), je imela nejasen glikemični odgovor na eksenatid v obliki s takojšnjim sproščanjem.
What Byetta is and what it is used for 
Kaj je zdravilo Byetta in za kaj ga uporabljamo
Unscrew and dispose of properly. 
Odvijte jo ter ustrezno zavrzite.
• Attach a new needle and repeat New Pen Setup, Steps B - E, in Section 2 of this user manual. 
• Pritrdite novo iglo in ponovite pripravo novega injekcijskega peresnika, Korake B - E, v Poglavju 2 tega Priročnika za uporabo.
You have diabetes because your body does not make enough insulin to control the level of sugar in your blood or if your body is not able to use the insulin properly. 
Sladkorno bolezen imate, ker vaše telo ne proizvede zadosti insulina za nadzor ravni sladkorja v vaši krvi ali ker vaše telo ne more pravilno uporabiti insulina.
If you are pregnant, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine, as it should not be used during pregnancy. 
Če ste noseči, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte z zdravnikom ali farmacevtom, preden vzamete to zdravilo, saj med nosečnostjo zdravila Byetta ne smete uporabljati.
• When it is time for your next routine dose, go to Section 3, Step 1, and repeat Steps 1 -7. 
• Ko je čas za vaš naslednji redni odmerek, pojdite na Poglavje 3, Korak 1 ter ponovite Korake
This prevents the liquid from leaking out. 
To prepreči iztekanje tekočine.
The amino acid sequence of exenatide partially overlaps that of human GLP-1. 
Aminokislinsko zaporedje eksenatida se delno prekriva z zaporedjem humanega GLP-1.
However, if you are also using a sulphonylurea or an insulin your doctor may tell you to check your blood sugar levels to adjust the dose of sulphonylurea or insulin. 
Vendar, če uporabljate tudi sulfonilsečnino ali insulin, vam bo vaš zdravnik morda priporočal, da preverjate vaše ravni sladkorja v krvi za prilagoditev odmerka sulfonilsečnine ali insulina.
- Two pre-filled pens are available. 
- Na voljo sta dva napolnjena injekcijska peresnika.
• If you do not see a stream or several drops come from the needle tip, repeat Steps C & D. 
• Če iz konice igle ne izhaja curek ali nekaj kapelj, ponovite Koraka C in D.
60 doses (2.4 ml) 
60 odmerkov (2,4 ml)
This may happen if the skin is pinched too tightly or if the pressure on the injection button is released before the needle is removed from the skin. 
Do tega lahko pride, če kožo premočno stiskate ali če popustite pritisk na gumb za injiciranje, preden iglo izvlečete iz kože.
The most frequently reported single adverse reaction was nausea which was associated with the initiation of treatment and decreased over time. 
Najpogostejši posamezni neželeni učinek je bila navzea, ki je bila povezana z začetkom zdravljenja in se je sčasoma zmanjšala.
• The purpose of the setup is to make sure that your Byettapen is ready to use for the next 30 days. 
• Namen priprave je zagotovitev, da je vaš injekcijski peresnik Byetta pripravljen za odmerjanje za naslednjih 30 dni.
• itching (with or without rash) 
• srbenje (z ali brez izpuščaja)
Your doctor is now prescribing Byetta as an additional medicine to help control your blood sugar. 
Vaš zdravnik vam je predpisal zdravilo Byetta kot dodatno zdravilo, ki vam bo pomagalo nadzorovati vrednosti vašega sladkorja v krvi.
- If you have ever had inflammation of the pancreas (pancreatitis) (see section 4). 
- Če ste kdaj imeli vnetje trebušne slinavke (pankreatitis) (glejte poglavje 4).
Severe allergic reactions (anaphylaxis) have been reported rarely (may affect up to 1 in 1,000 people). 
Redko so poročali o hudih alergijskih reakcijah (anafilaksija) (pojavijo se lahko pri največ 1 od 1.000 bolnikov).
Back 
Zadaj
Exenatide has not been studied in patients with severe gastrointestinal disease, including gastroparesis. 
Uporabe eksenatida niso preučevali pri bolnikih s hudo boleznijo prebavil, vključno z gastroparezo.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, particularly: - medicines that are used to treat type 2 diabetes that work like Byetta (e.g. liraglutide and prolonged-release exenatide), as taking these medicines with Byetta is not recommended. 
Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo, še posebno: - zdravila, ki se uporabljajo za zdravljenje sladkorne bolezni tipa 2, ki delujejo tako kot zdravilo Byetta (npr. liraglutid in eksenatid v obliki s podaljšanim sproščanjem), ker se jemanje teh zdravil z zdravilom Byetta ne priporoča.
The signs and symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, sweating, and feeling jittery. 
Znaki in simptomi nizkega sladkorja v krvi lahko vključujejo glavobol, zaspanost, slabotnost, omotičnost, zmedenost, razdražljivost, lakoto, hitro bitje srca, znojenje in občutek živčnosti.
What should I do if Byetta does not come out of the needle tip after four tries during New Pen Setup? 
Kaj naj storim, če zdravilo Byetta ne priteče iz konice igle po štirih poskusih priprave novega injekcijskega peresnika?
Fertility No fertility studies in humans have been conducted. 
Plodnost Študij plodnosti na ljudeh niso izvedli.
CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 
VSEBINA, IZRAŽENA S MASO, PROSTORNINO ALI ŠTEVILOM ENOT
Metformin or sulphonylureas 
Metformin in sulfonilsečnine
60 doses (1.2 ml) 
60 odmerkov (1,2 ml)
• Healthcare professionals or other caregivers should follow local or institutional policies regarding needle handling. 
• Zdravstveni delavci ali drugo negovalno osebje mora glede ravnanja z iglami slediti lokalnim smernicam ali smernicam ustanov.
Do not throw away. 
Ne zavrzite je.
Your doctor or nurse must teach you how to inject Byetta before you use it for the first time. 
Vaš zdravnik ali medicinska sestra vas morata pred prvo uporabo poučiti o tem, kako si injicirati zdravilo Byetta.
• Go to Section 3, Step 3, for instructions on how to inject your first routine dose. 
• Pojdite na Poglavje 3, Korak 3 za navodila glede injiciranja vašega prvega odmerka pri vsakodnevni uporabi.
You should inject this medicine at any time within the 60 minutes (1 hour) before your morning and evening meals, or before your two main meals of the day, which should be about 6 hours or more apart. 
To zdravilo si morate injicirati kadarkoli v roku 60 minut (1 ure) pred vašim jutranjim in večernim obrokom ali pred dvema vašima glavnima dnevnima obrokoma, ki naj bosta časovno približno 6 ur ali več narazen.
Rate based on immediate-release exenatide completed long-term efficacy and safety studies n=5763 total (patients on sulphonylurea n=2971). 
Pogostnost na podlagi dokončanih dolgoročnih študij učinkovitosti in varnosti eksenatida v obliki s takojšnjim sproščanjem, n skupaj = 5763, (število bolnikov na sulfonilsečnini n = 2971).
For instructions for using the pen, see section 6.6 and the user manual included with the leaflet. 
Za navodila o uporabi injekcijskega peresnika glejte poglavje 6.6 in navodila, ki so priložena navodilu za uporabo.
• Follow the instructions for hygienic injection technique recommended by your healthcare professional. 
• Sledite navodilom o higienski tehniki injiciranja, ki jo priporoča vaš zdravstveni delavec.
If such medicinal products are to be administered with food, patients should be advised to, if possible, take them with a meal when immediate-release exenatide is not administered. 
Če se ta zdravila jemljejo s hrano, moramo bolnikom svetovati, da jih, če je mogoče, vzamejo med obrokom, ko ne vzamejo eksenatida v obliki s takojšnjim sproščanjem.
If you are using insulin, your doctor will tell you how to reduce the dose of insulin and will recommend that you monitor your blood sugar more frequently, in order to avoid hyperglycaemia (high blood sugar) and diabetic ketoacidosis (a complication of diabetes that occurs when the body is unable to break down glucose because there is not enough insulin). 
Če uporabljate insulin, vam bo zdravnik povedal, kako zmanjšate odmerek insulina, in priporočil pogostejše spremljanje sladkorja, da s tem preprečite pojav hiperglikemije (visoka raven sladkorja v krvi) in diabetične ketoacidoze (zaplet pri sladkorni bolezni, ki nastopi, ko telo zaradi pomanjkanja insulina ni sposobno razgraditi glukoze).
(See Storing Your ByettaPenin Section 1 of this user manual for more information.) 
(Za več informacij glejte Shranjevanje vašega injekcijskega peresnika Byetta v Poglavju 1 tega Priročnika za uporabo.)
If you use more Byetta than you should 
Če ste uporabili večji odmerek zdravila Byetta, kot bi smeli
Overall, the percentage of antibody positive patients was consistent across clinical trials. 
Celostno je bil odstotek bolnikov s pozitivnimi protitelesi v kliničnih preskušanjih podoben.
• dehydration, generally associated with nausea, vomiting and/or diarrhoea 
• dehidracija, običajno pridružena slabosti, bruhanju in/ali driski
Exenatide has been shown to bind to and activate the known human GLP-1 receptor in vitro, its mechanism of action mediated by cyclic AMP and/or other intracellular signalling pathways. 
Pokazali so, da se eksenatid in vitro veže na in aktivira znani humani receptor GLP-1, katerega mehanizem delovanja posreduje ciklični AMP in/ali druge znotrajcelične poti sporočanja.
In the three placebo-controlled trials (n=963) 38% of patients had low titre anti-exenatide antibodies at 30 weeks. 
V treh s placebom nadzorovanih preskušanjih (n=963) je imelo 38 % bolnikov po 30 tednih nizke titre protiteles proti eksenatidu.
This incidence was not statistically significant when adjusted for survival. 
Ta incidenca pri prilagoditvi za preživetje ni bila statistično značilna.
Failure to follow these instructions completely may result in a wrong dose, a broken pen or an infection. 
Neupoštevanje teh navodil lahko povzroči nepravilno odmerjanje zdravila, lahko pride do poškodbe injekcijskega peresnika ali infekcije.
• The cartridge in your Byetta pen may not have enough liquid to deliver a full dose. 
• Vložek vašega injekcijskega peresnika Byetta morda ne vsebuje zadosti tekočine za dajanje celotnega odmerka.
Signs and symptoms of overdose may include severe nausea, severe vomiting and rapidly declining blood glucose concentrations. 
Znaki in simptomi prevelikega odmerjanja lahko vključujejo hudo navzeo, hudo bruhanje in hitro padanje koncentracije glukoze v krvi.